Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Micro Penny Stocks, Penny Stocks $0.10 & Under
»
PGPM..HUGE ALERT..LOOK AT THE PR JUST OUT!
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by ArmySGT: [QB] COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES: *********.com: ********* Alerts for Thursday, June 1, 2006 ACL Semiconductors Reports on Supply and Demand While UVICF Reports 35% Sales Growth Dallas, Texas, Jun 01, 2006 (M2 PRESSWIRE via COMTEX) -- ********* Pre-Market Updates for Thursday include Chaparral Resources Inc (OTCBB: CHAR),ACL Semiconductors Inc. (OTCBB: ACLO), Unilens Vision Inc (OTCBB: UVICF) , Pilgrim Petroleum Corporation (OTC: PGPM), First Trust Bank (OTCBB: NCFT) and Javelin Pharmaceuticals, Inc. (OTCBB: JVPH).********* Price Alerts feature companies with significant moves in either volume or price in the past two trading sessions. In our update we analyze recent news about the companies featured and detail the movement in the stock. If you would like to feature your publicly traded company in our alerts or on *********.com, email feature**********.com or call (469)252-3031. Chaparral Resources Inc (OTCBB: CHAR) - Shares closed down .35% on Wednesday. Price per share was $5.75 and total volume was 42,184. The Company recently reported its financial results for the first quarter 2006. The Company reported net income of $9.86 million, or 26 cents per share, for the quarter ended March 31, 2006, compared to $3.83 million, or 10 cents per share, for the quarter ended March 31, 2005. The $6.02 million increase in Chaparral's net income primarily relates to higher revenues as a result of higher prices and higher sales volumes achieved during the first quarter of 2006. Revenues were $53.45 million for the first quarter of 2006 compared with $24.33 million for the first quarter of 2005. The increase is the result of higher crude prices achieved during the first quarter of 2006 as compared to the same period of 2005, and due to higher sales volumes. The increase in revenues for the quarter was offset by increased transportation costs, administrative costs, minority interests and tax charges. The Company has also incurred $4.43 million of Excess Profits Tax payable in the Republic of Kazakhstan in the quarter ended March 31, 2006. There was no corresponding charge in the first quarter of 2005.During 2006, the Company expects to increase production by drilling 12 new wells, converting further wells to artificial lift and adding further water injection wells. The Company will continue with the development of the Karakuduk Field throughout the remainder of 2006. By the end of the third quarter it hopes to have two, possibly even three drilling rigs operational at the field. The Company forecasts that up to 10 further wells will be drilled, with a total program of some 38,400 meters expected to be drilled during the year. Boris Zilbermints, Chief Executive Officer of Chaparral, commented, 'The positive results of the first quarter reflect the hard work and technical expertise of our staff as well as the global increase in oil prices. On the other hand, the harsh winter weather as well as the delays with our drilling program and imposition of the Kazakh Excess Profits Tax has adversely impacted our results.' Chaparral Resources, Inc. is an oil and gas development and production company. The Company's only operating asset is its participation in the development of the Karakuduk Field, in the Republic of Kazakhstan, through KKM, which is the operating company. The Company has directly and indirectly a 60% ownership interest in KKM with the other 40% ownership interest being held by Caspian which holds a majority interest in Chaparral and operates several other producing oil fields in Kazakhstan. More information is available on the Company's web site, [URL=http://www.chaparralresources.com.]www.chaparralresources.com.[/URL] ACL Semiconductors Inc. (OTCBB: ACLO) - Wednesday's shares gained 11.11% for a closing price of $.20 per share. Trade volume totaled 15,000 shares. The Company has recently reported on memory chip supply and demand. ACLO supplies this information to Samsung HK and its other customers to provide insight into market conditions. The flash market saw 4 Gb flash components increasing in contract price by 12% recently due to the fact that Sony and Apple are negotiating the 2nd half production plan with Samsung. Also, production of 8Gb and 16Gb is the main manufacturer's focus, leaving the 4Gb flash component (which is for the 512 MB memory card bundled into mobile cell phones) in tight supply. DDRI market is showing tight supply and the relative shortage of the DDRI could last into the summer months as most manufacturers have switched their production lines to DDRII. DDRII prices are quite stable recently and we anticipate we will see even more market activity in June. Recent comments from Merrill Lynch analysts to the memory component sector were upbeat. "Both spot and contract DRAM prices have hovered about 5% to 10% higher than our expectations through April-May. This indicates upbeat second-quarter results despite demand that has been seasonally normal at best." Further, "We expect pure-play DRAM and NAND stocks to outperform in the overall tech sector. For the short-term, however, we would continue to prefer DRAM to NAND. Long term, higher growth or margin upside comes from NAND compared with DRAM," were among the highlights of the research notes provided by CFAs from Merrill Lynch in last week's report. "We are encouraged by recent supply and demand data and industry analyst's comments. Indeed the outlook for our core business remains robust," cited ACL Chairman, Alan Yang. "In addition to our longstanding leadership in memory component distribution, we also continue to seek synergistic opportunities to bolster profit margins and we look forward to making progress towards these goals in 2006." ACL has been a leading distributor of Samsung memory chip products, including DRAM, Flash, SRAM and Mask ROM products, for the Hong Kong and Southern China markets since 1991. ACL Semiconductors, Inc. trades on the OTCBB under the symbol ACLO. Unilens Vision Inc (OTCBB: UVICF) - Shares held steady at $3.65. Wednesday's volume was 300 shares. Unilens Vision Inc. has reported higher sales, earnings, and royalty income for the third quarter and first nine months of FY2006. Net sales, excluding royalty income, increased 25% to $1,585,086 for the three months ended March 31, 2006, compared with $1,270,592 for the third quarter of the previous fiscal year. The sales increase was primarily the result of continued growth in sales of the Company's C-Vue multifocal and toric multifocal contact lenses to eye care professionals. Sales associated with the SoftCon EW and Aquaflex brands that the Company acquired from CIBA Vision at the end of February 2005 accounted for approximately 10% of sales during the most recent quarter and 11% of sales for the nine months ended March 31, 2006. Royalty income for the quarter ended March 31, 2006 increased 18% to $489,551. Net income increased 16% to $314,689, or $0.07 per diluted share. 'We are pleased to report another quarter of double-digit percentage growth in sales, earnings and royalty income,' stated A. W. Vitale, Chief Executive Officer of Unilens Vision Inc. Based on currently available information, we anticipate record revenue and income before taxes and extraordinary items for the Fiscal Year ending June 30, 2006.' For the nine months ended March 31, 2006, net sales, excluding royalty income, rose 34% to $4,559,686, versus $3,402,271 in the corresponding period of the previous fiscal year. Royalty income for the nine months ended March 31, 2006 increased 26% to $1,463,446, compared with $1,158,424 in the prior-year period. The Company's net income increased 30% to $941,564, or $0.21 per diluted share, for the first nine months of FY2006, compared with $722,669, or $0.16 per diluted share, for the comparable nine months of FY2005. 'Our financial condition at the end of the most recent quarter was the strongest in the Company's history,' continued Vitale. 'During the past twelve months, we have reduced our total liabilities by 37%, to $755,260, while our shareholders' equity has increased 55% to over $7.3 Million. Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets specialty contact lenses under the C-VUE, Unilens, Sof-Form, Lombart, and LifeStyle brands. Additional information on the Company may be accessed on the Internet at http://www.unilens.com . The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVICF" as well as the TSX Venture Exchange under the symbol "UVI". Pilgrim Petroleum Corporation (OTC: PGPM) - Wednesday's shares closed down 29.08%. Price per share was $.10 and volume closed at 12,720,208 shares. The Company announced financial analysis and considerations on the profitability of developing the 4 million BOE by spreading the exploitation of 4 million barrels with an average of $65 per barrel of oil in 4 years. Based on these Gustavson's report assumptions and NPV analysis , the following was provided: With the assumption of an initial investment of $10 million and potential cash inflows of $65 million (assuming 1 million BOE per year at $65 oil price) then our PV at a discount rate of 10% would be $206,043,500, meaning a positive NPV of $196,037,000. A complete economic report and company valuation is on progress, based on the above analysis and will be part of the audit required for our SEC filing. Rafael Pinedo, CEO of Pilgrim Petroleum Corporation, commented, "These additional inflows will definitely make a direct impact in the fair value of the company and should bring the value of our stock up considerably, without considering variables like oil prices, new acquisitions and partnerships, etc." Pilgrim Petroleum Corporation (OTCBB:PGPM) is an independent oil and gas company based in Irving, Texas. The company is acquiring oil and gas leases, producing properties, mineral rights, and surface interests in Texas. Once acquired, the company intends to develop each property to maximize the income from each property by refurbishing and improving the existing production. First Trust Bank (OTCBB: NCFT) - Shares were unchanged on Wednesday at $23.90 per share. Total volume was 300 shares. William D. Elder has joined the First Trust Bank as Senior Vice President/Senior Loan Officer in its headquarters office at 1420 East Third Street, Charlotte, NC. Bill has over thirty years of commercial and consumer banking experience and is committed to the Bank's mission of providing the highest quality professional financial services to its customers and shareholders. 'Bill's seasoned experience will greatly enhance the depth of our commercial lending team,' said Jim Bolt, President/CEO of First Trust Bank. First Trust Bank specializes in serving the banking needs of small businesses and professionals in the Charlotte, Mooresville, Davidson, Cornelius, Huntersville and Concord markets. The bank operates three banking offices located at 1420 East Third Street and 2245 Rexford Road, Charlotte, NC and 108 Gateway Boulevard, Mooresville, NC and a loan production office at 916 Copperfield Boulevard in Concord, NC. Javelin Pharmaceuticals, Inc. (OTCBB: JVPH) - Shares gained 7.35% on Wednesday, trading 6,312 shares. The price per share was $3.65. Javelin has announced treatment of the first patient in its Phase III clinical program for its injectable NSAID, Dyloject(TM) (diclofenac sodium). This pivotal US study will enroll 360 patients with moderate-to-severe postoperative pain following abdominal surgery. A second pivotal US study in a different postoperative pain model (orthopedic surgery) is planned to begin later this year. 'Javelin has now commenced enrollment in Phase III programs for two of its three product candidates this month,' said Dr. Daniel Carr, the Company's Chief Executive Officer and Chief Medical Officer. 'As with our other Phase III program for the intranasal morphine product Rylomine(TM), in both cases a productive end-of-Phase II meeting with the FDA allowed us to define a straightforward path to regulatory approval. Javelin's development team has been highly effective in bringing these two product candidates into Phase III clinical testing nearly simultaneously.'This study follows the successful completion of a 353 patient Phase IIb study of Dyloject(TM) in patients with postoperative pain. Javelin's Phase II studies of this nonselective NSAID showed it to be well tolerated, with a quicker onset, equal duration of effect, and less associated phlebitis than Voltarol(TM), the injectable diclofenac formulation currently marketed in Europe. An application to market Dyloject(TM) was filed last fall in Europe. Results of the latest Phase IIb study have been submitted for presentation at the annual meeting of the European Federation of IASP Chapters in September 2006. Javelin is a specialty pharmaceutical company, applying innovative, proprietary technologies to develop new drugs and improved formulations of existing drugs to target unmet and underserved medical needs in the pain management market. For additional information please visit the website [URL=http://www.javelinpharmaceuticals.com.]www.javelinpharmaceuticals.com.[/URL] About *********.com: *********.com features daily alerts going out three times daily to members. To join our email alert list, please visit: http://www.*********.com/stocks.htm To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031. Our services include our ********* Pre-Market Alerts, ********* Volume Alerts, ********* Price Alerts, ********* Midday Alerts, and ********* After The Bell. Additionally we Profile publicly traded companies on our web site, we do interviews with CEO's or other key executives on our web site, and we have our financial writers cover our companies. Those interested may also email: feature**********.com or call (469) 252-3031 and we will gladly send more information on featuring your company with *********.com. *********.com ("SG") provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.*********.com or mentioned herein. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. CONTACT: John Pentony, Publisher Tel: +1 469 252 3031 e-mail: feature**********.com M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info*m2.com. (C)1994-2006 M2 COMMUNICATIONS LTD -0- [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2